Akèy › Anplwayè › Audentes Therapeutics Inc
Audentes Therapeutics Inc: Salè H-1B ak pajon
Audentes Therapeutics Inc depoze 3 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 3. Medyèn salè yo ofri a: $122,000.
Èske Audentes Therapeutics Inc pajone visa H-1B?
Audentes Therapeutics Inc depoze 3 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Sep 6, 2023. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Validation Engineer | 1 | $122,000 |
| Associate Director, Gene Therapy Competitive Intelligence | 1 | $145,500 |
| Research Associate II, Vector Production | 1 | $76,461 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 3 | $122,000 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Industrial Engineers1
- Market Research Analysts and Marketing Specialists1
- Molecular and Cellular Biologists1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Research Associate II, Vector Production | $76,461–$96,000 Nivo I | South San Francisco, CA | Sep 6, 2023 | Oct 1, 2023 | Certifye |
| Validation Engineer | $122,000 Nivo IV | Sanford, NC | Mar 13, 2023 | Apr 17, 2023 | Certifye |
| Associate Director, Gene Therapy Competitive Intelligence | $145,500–$242,500 Nivo IV | Redwood City, CA | Jan 17, 2023 | Mar 13, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).